These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1971177)

  • 1. Syntheses of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298), selective ligands for the study of dopamine D-2 receptors.
    Högberg T; Ström P; Hall H; Köhler C; Halldin C; Farde L
    Acta Pharm Nord; 1990; 2(1):53-60. PubMed ID: 1971177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.
    Hall H; Högberg T; Halldin C; Köhler C; Ström P; Ross SB; Larsson SA; Farde L
    Psychopharmacology (Berl); 1991; 103(1):6-18. PubMed ID: 1672460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro receptor binding characteristics of the new dopamine D2 antagonist [125I]NCQ-298: methodological considerations of high affinity binding.
    Jerning E; Malmberg A; Mohell N
    J Recept Signal Transduct Res; 1995; 15(1-4):503-15. PubMed ID: 8903960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding.
    Halldin C; Farde L; Högberg T; Hall H; Ström P; Ohlberger A; Solin O
    Int J Rad Appl Instrum B; 1991; 18(8):871-81. PubMed ID: 1839303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of dopamine D2-receptor selective antagonists.
    Högberg T
    Drug Des Discov; 1993; 9(3-4):333-50. PubMed ID: 8400011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
    J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.
    Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM
    J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides.
    de Paulis T; Kumar Y; Johansson L; Rämsby S; Hall H; Sällemark M; Angeby-Möller K; Ogren SO
    J Med Chem; 1986 Jan; 29(1):61-9. PubMed ID: 3941414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [123I]IBZM SPET analysis of dopamine D2 receptor occupancy in narcoleptic patients in the course of treatment.
    Staedt J; Stoppe G; Kögler A; Riemann H; Hajak G; Rodenbeck A; Mayer G; Steinhoff BJ; Munz DL; Emrich D; Rüther E
    Biol Psychiatry; 1996 Jan; 39(2):107-11. PubMed ID: 8717608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
    Schonwetter BS; Luedtke RR; Kung MP; Billings J; Kung HF; Molinoff PB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):110-6. PubMed ID: 2526213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
    Malmberg A; Jerning E; Mohell N
    Eur J Pharmacol; 1996 May; 303(1-2):123-8. PubMed ID: 8804920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors.
    de Paulis T; Janowsky A; Kessler RM; Clanton JA; Smith HE
    J Med Chem; 1988 Oct; 31(10):2027-33. PubMed ID: 3172140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
    Zhuang ZP; Kung MP; Mu M; Kung HF
    J Med Chem; 1998 Jan; 41(2):157-66. PubMed ID: 9457239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
    Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ
    Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2 receptors in the rat, monkey and the post-mortem human hippocampus. An autoradiographic study using the novel D2-selective ligand 125I-NCQ 298.
    Köhler C; Ericson H; Högberg T; Halldin C; Chan-Palay V
    Neurosci Lett; 1991 Apr; 125(1):12-4. PubMed ID: 1677461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
    Booij J; Andringa G; Rijks LJ; Vermeulen RJ; De Bruin K; Boer GJ; Janssen AG; Van Royen EA
    Synapse; 1997 Nov; 27(3):183-90. PubMed ID: 9329154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
    J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors.
    Hall H; Halldin C; Jerning E; Osterlund M; Farde L; Sedvall G
    Nucl Med Biol; 1997 Jul; 24(5):389-93. PubMed ID: 9290072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.